Table 1.

Baseline Characteristics

NNRTI (N = 65)
PI (N = 62)
INSTI (N = 19)
TOTAL (N = 146)
P Value
nMean (SD)nMean (SD)nMean (SD)nMean (SD)
Age, y6545.1 (10.5)6242.8 (10.5)1944.1 (7.3)14644 (10.7)0.588a
Sex, % male5381.55182.31368.411780.10.388b
Risk practice
 MSM, %2944.62337.1736.85940.40.65a
 Other, %3654.43962.91963.28759.6
AIDS, yes, %812.71219.4002013.90.096b
CD4, cells/mL65262 (173.9)62233.1 (164.1)19319.8 (112.5)146257.23 (164.38)0.057a
Viral load, log10655.45 (5.89)625.5 (5.8)195.1 (5.3)1465.44 (5.81)0.391a
Total cholesterol, mmol/L654.4 (1)624.1 (1)194.2 (0.8)1464.26 (0.99)0.218a
LDL, mmol/L642.7 (0.8)622.3 (0.9)192.6 (0.7)1452.5 (0.8)0.051a
HDL, mmol/L651.1 (0.3)621 (0.4)191 (0.3)1461.05 (0.35)0.189a
Ratio T Ch:HDL, mmol/L654.3 (1.6)624.4 (1.5)194.8 (3)1464.42 (1.80)0.967a
TG, mmol/L651.5 (0.6)621.7 (1)191.3 (0.5)1461.5 (0.8)0.622a
BMI6525 (3.6)6224.1 (3.9)1924.8 (3.2)14624.6 (3.7)0.413a
Time to first DXA scan, d, mean (95% CI)6520.6 (14.5–26.7)6224 (15.3–32.7)1935.5 (17.8–53.2)14624.0 (18.8–29.2)0.117a
Limb fat, g657016.7 (3138.8)626510.4 (3474.8)196467.6 (2740.3)1466730.3 (3229.0)0.5021b
Trunk fat, g657572.8 (3958.7)627172.9 (4499.7)197464.6 (3670.5)1467388.9 (4140.4)0.4871b
Total fat, g6515,513.6 (6816.2)6214,345.8 (7660.4)1914,842 (6309.3)14614,930.3 (7101.7)0.3781b
FMR651 (0.3)621 (0.3)191 (0.2)1460.98 (0.26)0.8271b
Lean mass, g
 Trunk6525,992.63 (3970.56)6225,192.01 (4256.37)1925,636.85 (4705.86)14625,606.34 (4179.65)0.6232b
 Limbs6523,845.21 (4775.66)6223,098.81 (4681.46)1923,250.12 (5775.65)14623,450.8 (4853.39)0.7212b
 Total6553,860.48 (8634.93)6252,416.49 (9086.19)1952,842.12 (10,530.63)14653,114.75 (9048.51)0.7162b
FFMI6518.40 (1.9)6217.92 (2.5)1918.25 (2.37)14618.18 (2.25)0.49
NNRTI (N = 65)
PI (N = 62)
INSTI (N = 19)
TOTAL (N = 146)
P Value
nMean (SD)nMean (SD)nMean (SD)nMean (SD)
Age, y6545.1 (10.5)6242.8 (10.5)1944.1 (7.3)14644 (10.7)0.588a
Sex, % male5381.55182.31368.411780.10.388b
Risk practice
 MSM, %2944.62337.1736.85940.40.65a
 Other, %3654.43962.91963.28759.6
AIDS, yes, %812.71219.4002013.90.096b
CD4, cells/mL65262 (173.9)62233.1 (164.1)19319.8 (112.5)146257.23 (164.38)0.057a
Viral load, log10655.45 (5.89)625.5 (5.8)195.1 (5.3)1465.44 (5.81)0.391a
Total cholesterol, mmol/L654.4 (1)624.1 (1)194.2 (0.8)1464.26 (0.99)0.218a
LDL, mmol/L642.7 (0.8)622.3 (0.9)192.6 (0.7)1452.5 (0.8)0.051a
HDL, mmol/L651.1 (0.3)621 (0.4)191 (0.3)1461.05 (0.35)0.189a
Ratio T Ch:HDL, mmol/L654.3 (1.6)624.4 (1.5)194.8 (3)1464.42 (1.80)0.967a
TG, mmol/L651.5 (0.6)621.7 (1)191.3 (0.5)1461.5 (0.8)0.622a
BMI6525 (3.6)6224.1 (3.9)1924.8 (3.2)14624.6 (3.7)0.413a
Time to first DXA scan, d, mean (95% CI)6520.6 (14.5–26.7)6224 (15.3–32.7)1935.5 (17.8–53.2)14624.0 (18.8–29.2)0.117a
Limb fat, g657016.7 (3138.8)626510.4 (3474.8)196467.6 (2740.3)1466730.3 (3229.0)0.5021b
Trunk fat, g657572.8 (3958.7)627172.9 (4499.7)197464.6 (3670.5)1467388.9 (4140.4)0.4871b
Total fat, g6515,513.6 (6816.2)6214,345.8 (7660.4)1914,842 (6309.3)14614,930.3 (7101.7)0.3781b
FMR651 (0.3)621 (0.3)191 (0.2)1460.98 (0.26)0.8271b
Lean mass, g
 Trunk6525,992.63 (3970.56)6225,192.01 (4256.37)1925,636.85 (4705.86)14625,606.34 (4179.65)0.6232b
 Limbs6523,845.21 (4775.66)6223,098.81 (4681.46)1923,250.12 (5775.65)14623,450.8 (4853.39)0.7212b
 Total6553,860.48 (8634.93)6252,416.49 (9086.19)1952,842.12 (10,530.63)14653,114.75 (9048.51)0.7162b
FFMI6518.40 (1.9)6217.92 (2.5)1918.25 (2.37)14618.18 (2.25)0.49

Abbreviations: DXA, dual X-ray absorptiometry; T Ch, total cholesterol; TG, triglycerides.

a

Kruskal-Wallis test.

b

ANOVA.

Table 1.

Baseline Characteristics

NNRTI (N = 65)
PI (N = 62)
INSTI (N = 19)
TOTAL (N = 146)
P Value
nMean (SD)nMean (SD)nMean (SD)nMean (SD)
Age, y6545.1 (10.5)6242.8 (10.5)1944.1 (7.3)14644 (10.7)0.588a
Sex, % male5381.55182.31368.411780.10.388b
Risk practice
 MSM, %2944.62337.1736.85940.40.65a
 Other, %3654.43962.91963.28759.6
AIDS, yes, %812.71219.4002013.90.096b
CD4, cells/mL65262 (173.9)62233.1 (164.1)19319.8 (112.5)146257.23 (164.38)0.057a
Viral load, log10655.45 (5.89)625.5 (5.8)195.1 (5.3)1465.44 (5.81)0.391a
Total cholesterol, mmol/L654.4 (1)624.1 (1)194.2 (0.8)1464.26 (0.99)0.218a
LDL, mmol/L642.7 (0.8)622.3 (0.9)192.6 (0.7)1452.5 (0.8)0.051a
HDL, mmol/L651.1 (0.3)621 (0.4)191 (0.3)1461.05 (0.35)0.189a
Ratio T Ch:HDL, mmol/L654.3 (1.6)624.4 (1.5)194.8 (3)1464.42 (1.80)0.967a
TG, mmol/L651.5 (0.6)621.7 (1)191.3 (0.5)1461.5 (0.8)0.622a
BMI6525 (3.6)6224.1 (3.9)1924.8 (3.2)14624.6 (3.7)0.413a
Time to first DXA scan, d, mean (95% CI)6520.6 (14.5–26.7)6224 (15.3–32.7)1935.5 (17.8–53.2)14624.0 (18.8–29.2)0.117a
Limb fat, g657016.7 (3138.8)626510.4 (3474.8)196467.6 (2740.3)1466730.3 (3229.0)0.5021b
Trunk fat, g657572.8 (3958.7)627172.9 (4499.7)197464.6 (3670.5)1467388.9 (4140.4)0.4871b
Total fat, g6515,513.6 (6816.2)6214,345.8 (7660.4)1914,842 (6309.3)14614,930.3 (7101.7)0.3781b
FMR651 (0.3)621 (0.3)191 (0.2)1460.98 (0.26)0.8271b
Lean mass, g
 Trunk6525,992.63 (3970.56)6225,192.01 (4256.37)1925,636.85 (4705.86)14625,606.34 (4179.65)0.6232b
 Limbs6523,845.21 (4775.66)6223,098.81 (4681.46)1923,250.12 (5775.65)14623,450.8 (4853.39)0.7212b
 Total6553,860.48 (8634.93)6252,416.49 (9086.19)1952,842.12 (10,530.63)14653,114.75 (9048.51)0.7162b
FFMI6518.40 (1.9)6217.92 (2.5)1918.25 (2.37)14618.18 (2.25)0.49
NNRTI (N = 65)
PI (N = 62)
INSTI (N = 19)
TOTAL (N = 146)
P Value
nMean (SD)nMean (SD)nMean (SD)nMean (SD)
Age, y6545.1 (10.5)6242.8 (10.5)1944.1 (7.3)14644 (10.7)0.588a
Sex, % male5381.55182.31368.411780.10.388b
Risk practice
 MSM, %2944.62337.1736.85940.40.65a
 Other, %3654.43962.91963.28759.6
AIDS, yes, %812.71219.4002013.90.096b
CD4, cells/mL65262 (173.9)62233.1 (164.1)19319.8 (112.5)146257.23 (164.38)0.057a
Viral load, log10655.45 (5.89)625.5 (5.8)195.1 (5.3)1465.44 (5.81)0.391a
Total cholesterol, mmol/L654.4 (1)624.1 (1)194.2 (0.8)1464.26 (0.99)0.218a
LDL, mmol/L642.7 (0.8)622.3 (0.9)192.6 (0.7)1452.5 (0.8)0.051a
HDL, mmol/L651.1 (0.3)621 (0.4)191 (0.3)1461.05 (0.35)0.189a
Ratio T Ch:HDL, mmol/L654.3 (1.6)624.4 (1.5)194.8 (3)1464.42 (1.80)0.967a
TG, mmol/L651.5 (0.6)621.7 (1)191.3 (0.5)1461.5 (0.8)0.622a
BMI6525 (3.6)6224.1 (3.9)1924.8 (3.2)14624.6 (3.7)0.413a
Time to first DXA scan, d, mean (95% CI)6520.6 (14.5–26.7)6224 (15.3–32.7)1935.5 (17.8–53.2)14624.0 (18.8–29.2)0.117a
Limb fat, g657016.7 (3138.8)626510.4 (3474.8)196467.6 (2740.3)1466730.3 (3229.0)0.5021b
Trunk fat, g657572.8 (3958.7)627172.9 (4499.7)197464.6 (3670.5)1467388.9 (4140.4)0.4871b
Total fat, g6515,513.6 (6816.2)6214,345.8 (7660.4)1914,842 (6309.3)14614,930.3 (7101.7)0.3781b
FMR651 (0.3)621 (0.3)191 (0.2)1460.98 (0.26)0.8271b
Lean mass, g
 Trunk6525,992.63 (3970.56)6225,192.01 (4256.37)1925,636.85 (4705.86)14625,606.34 (4179.65)0.6232b
 Limbs6523,845.21 (4775.66)6223,098.81 (4681.46)1923,250.12 (5775.65)14623,450.8 (4853.39)0.7212b
 Total6553,860.48 (8634.93)6252,416.49 (9086.19)1952,842.12 (10,530.63)14653,114.75 (9048.51)0.7162b
FFMI6518.40 (1.9)6217.92 (2.5)1918.25 (2.37)14618.18 (2.25)0.49

Abbreviations: DXA, dual X-ray absorptiometry; T Ch, total cholesterol; TG, triglycerides.

a

Kruskal-Wallis test.

b

ANOVA.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close